Associated Papers
Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival.
Christopoulos P et al.
Cancers, 2019
30669647 (PubMed )
Supplement: cancers-11-00124-s001.pdf
Select a paper to view details